Quantified relations between exposure to tobacco smoking and bladder cancer risk: A meta-analysis of 89 observational studies

International Journal of Epidemiology

Volumn 45, Issue 3, 2016, Pages 857-870

  van Osch, Frits H M ^a,b   Jochems, Sylvia H J ^a,b   Schooten, Frederik Jan van ^a   Bryan, Richard T ^b   Zeegers, Maurice P ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Bladder cancer incidence; Dose response analyses; Meta analysis; Observational studies; Population attributable risk; Smoking

Indexed keywords

CANCER; DISEASE INCIDENCE; DOSE-RESPONSE RELATIONSHIP; HEALTH RISK; HETEROGENEITY; HOMOGENEITY; META-ANALYSIS; OBSERVATIONAL METHOD; PUBLIC HEALTH; SMOKING; TOBACCO;

ARTICLE; ASIAN; ATTRIBUTABLE RISK; BLADDER CANCER; CANCER RISK; EUROPE; HUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUANTITATIVE STUDY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SMOKING; SMOKING CESSATION; BLADDER TUMOR; FEMALE; MALE; META ANALYSIS; PROCEDURES; REGRESSION ANALYSIS; RISK FACTOR; TIME FACTOR;

ASIA; EUROPE;

NICOTIANA TABACUM;

FEMALE; HUMANS; MALE; OBSERVATIONAL STUDIES AS TOPIC; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SMOKING CESSATION; TIME FACTORS; TOBACCO SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84997525281     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyw044     Document Type: Article

References (127)

1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
2. Zeegers M, Tan FE, Dorant E, van den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk. Cancer 2000;89:630-39.
3. Organisation for Economic Co-operation and Development (OECD). Health at a Glance: Europe 2014. OECD Publishing. 2014 http://dx.doi.org/10.1787/health_glance:eur-2014-en (October 2015, date last accessed).
4. Agaku IT, King BA, Dube SR; Centers for Disease Control and Prevention. Current cigarette smoking among adults-United States, 2005-2012. MMWR Morb Mortal Wkly Rep 2014; 63:29-34.
5. Li Q, Hsia J, Yang G. Prevalence of smoking in China in 2010. N Engl J Med 2011;364:2469-70.
6. Letašiová S, Medve'Ova A, Šovčíková A et al. Bladder cancer, a review of the environmental risk factors. Environ Health 2012;11(Suppl 1):S11.
7. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004; 21:392-401.
8. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M; Comparative Risk Assessment Collaborating Group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784-93.
9. Wells G, Shea B, O'Connell D. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Ottawa, ON: Ottawa Hospital Research Institute, 2013.
10. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
11. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Metaanalysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012;175:66-73.
12. Dunham LJ, Rabson AS, Stewart HL, Frank AS, Young JL. Rates, Interview, and pathology study of cancer of the urinary bladder in NewOrleans, Louisiana. JNatl Cancer Inst 1968;41:683-709.
13. Anthony HM, Thomas GM. Bladder tumours and smoking. Int J Cancer 1970;5:266-72.
14. Armstrong B, Garrod A, Doll R. A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer 1976;33:127-36.
15. Miller A, Howe G. Artificial sweeteners and bladder cancer. Lancet 1977;310:1221-22.
16. Wynder EL, Stellman SD. Comparative epidemiology of tobacco-related cancers. Cancer Res 1977;37:4608-22.
17. Vineis P, Segnan N, Costa G, Terracini B. Evidence of a multiplicative effect between cigarette smoking and occupational exposures in the aetiology of bladder cancer. Cancer Lett 1981; 14:285-90.
18. Morrison AS, Buring JE, Verhoek WG et al. An international study of smoking and bladder cancer. J Urol 1984;131:650-54.
19. Rebelakos A, Trichopoulos D, Tzonou A, Zavitsanos X, Velonakis E, Trichopoulos A. Tobacco smoking, coffee drinking, and occupation as risk factors for bladder cancer in Greece. J Natl Cancer Inst 1985;75:455-61.
20. Sandler DP, Everson RB, Wilcox AJ. Passive smoking in adulthood and cancer risk. Am J Epidemiol 1985;121:37-48.
21. Vineis P, Ciccone G, Ghisetti V, Terracini B. Cigarette smoking and bladder cancer in females. Cancer Lett 1985;26:61-66.
22. Wynder EL, Dieck GS, Hall NE, Lahti H. A case-control study of diesel exhaust exposure and bladder cancer. Environ Res 1985;37:475-89.
23. Claude J, Kunze E, Frentzel-Beyme R, Paczkowski K, Schneider J, Schubert H. Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 1986;124:578-89.
24. Brownson RC, Chang JC, Davis JR. Occupation, smoking, and alcohol in the epidemiology of bladder cancer. Am J Public Health 1987;77:1298-300.
25. Hartge P, Silverman D, Hoover R et al. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst 1987;78:1119-25.
26. Augustine A, Hebert JR, Kabat GC, Wynder EL. Bladder cancer in relation to cigarette smoking. Cancer Res 1988;48: 4405-08.
27. Slattery ML, Schumacher MC, West DW, Robison LM. Smoking and bladder cancer. The modifying effect of cigarettes on other factors. Cancer 1988;61:402-08.
28. Steineck G, Norell SE, Feychting M. Diet, tobacco and urothelial cancer. A 14-year follow-up of 16, 477 subjects. Acta Oncol 1988;27:323-27.
29. Vineis P, Esteve J, Hartge P, Hoover R, Silverman DT, Terracini B. Effects of timing and type of tobacco in cigaretteinduced bladder cancer. Cancer Res 1988;48:3849-52.
30. Burch J, Rohan T, Howe G et al. Risk of bladder cancer by source and type of tobacco exposure: A case-control study. Int J Cancer 1989;44:622-28.
31. Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 1989;49:6144-48.
32. Ross RK, Paganini-Hill A, Landolph J, Gerkins V, Henderson BE. Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter. Cancer Res 1989;49:1045-48.
33. D'Avanzo B, Negri E, La Vecchia C et al. Cigarette smoking and bladder cancer. Eur J Cancer 1990;26:714-18.
34. Harris RE, Chen-Backlund JY, Wynder EL. Cancer of the urinary bladder in blacks and whites. A case-control study. Cancer 1990;66:2673-80.
35. Hartge P, Harvey EB, Linehan WM et al. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 1990;82:1636-40.
36. de Stefani E, Correa P, Fierro L, Fontham E, Chen V, Zavala D. Black tobacco, mate, and bladder cancer. A case-control study from Uruguay. Cancer 1991;67:536-40.
37. La Vecchia C, Negri E, D'Avanzo B, Savoldelli R, Franceschi S. Genital and urinary tract diseases and bladder cancer. Cancer Res 1991;51:629-31.
38. Lopez-Abente G, Gonzalez CA, Errezola M et al. Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain. Am J Epidemiol 1991;134:830-39.
39. Mills PK, Beeson WL, Phillips RL, Fraser GE. Bladder cancer in a low risk population: results from the Adventist Health Study. Am J Epidemiol 1991;133:230-39.
40. D'Avanzo B, La Vecchia C, Franceschi S, Negri E, Talamini R, Buttino I. Coffee consumption and bladder cancer risk. Eur J Cancer 1992;28A:1480-84.
41. Kunze E, Chang-Claude J, Frentzel-Beyrne R. Life style and occupational risk factors for bladder cancer in Germany. A casecontrol study. Cancer 1992;69:1776-90.
42. McLaughlin JK, Silverman DT, Hsing AW et al. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 1992;52:254-57.
43. Chyou P-H, Nomura AMY, Stemmermann GN. A prospective study of diet, smoking, and lower urinary tract cancer. Ann Epidemiol 1993;3:211-16.
44. Cordier S, Clavel J, Limasset JC et al. Occupational risks of bladder cancer in France: a multicentre case-control study. Int J Epidemiol 1993;22:403-11.
45. Hayes RB, Friedell GH, Zahm SH, Cole P. Are the known bladder cancer risk-factors associated with more advanced bladder cancer?. Cancer Causes Control 1993;4:157-62.
46. Barbone F, Franceschi S, Talamini R, Bidoli E, La Vecchia C. Occupation and bladder cancer in Pordenone (north-east Italy): a case-control study. Int J Epidemiol 1994;23:58-65.
47. Sorahan T, Lancashire RJ, Sole G. Urothelial cancer and cigarette smoking: findings from a regional case-controlled study. Br J Urol 1994;74:753-56.
48. Sturgeon SR, Hartge P, Silverman DT et al. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 1994;5:218-25.
49. D'Avanzo B, La Vecchia C, Negri E, Decarli A, Benichou J. Attributable risks for bladder cancer in northern Italy. Ann Epidemiol 1995;5:427-31.
50. Tremblay C, Armstrong B, Theriault G, Brodeur J. Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry. Am J Ind Med 1995;27:335-48.
51. Bruemmer B, White E, Vaughan TL, Cheney CL. Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol 1996;144:485-95.
52. Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26 000 Norwegian men and women. Cancer Causes Control 1996;7:497-506.
53. Bedwani R, el-Khwsky F, Renganathan E et al. Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer 1997;73:64-67.
54. Donato F, Boffetta P, Fazioli R, Aulenti V, Gelatti U, Porru S. Bladder cancer, tobacco smoking, coffee and alcohol drinking in Brescia, northern Italy. Eur J Epidemiol 1997;13:795-800.
55. Teschke K, Morgan MS, Checkoway H et al. Surveillance of nasal and bladder cancer to locate sources of exposure to occupational carcinogens. Occup Environ Med 1997;54:443-51.
56. Koivusalo M, Hakulinen T, Vartiainen T, Pukkala E, Jaakkola JJ, Tuomisto J. Drinking water mutagenicity and urinary tract cancers: a population-based case-control study in Finland. Am J Epidemiol 1998;148:704-12.
57. Sorahan T, Hamilton L, Wallace DM, Bathers S, Gardiner K, Harrington JM. Occupational urothelial tumours: a regional case-control study. Br J Urol 1998;82:25-32.
58. Pohlabeln H, Jockel KH, Bolm-Audorff U. Non-occupational risk factors for cancer of the lower urinary tract in Germany. Eur J Epidemiol 1999;15:411-19.
59. Pommer W, Bronder E, Klimpel A, Helmert U, Greiser E, Molzahn M. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 1999;14:2892-97.
60. Pesch B, Haerting J, Ranft U, Klimpel A, Oelschlagel B, Schill W. Occupational risk factors for urothelial carcinoma: agentspecific results from a case-control study in Germany. MURC Study Group. Multicenter Urothelial and Renal Cancer. Int J Epidemiol 2000;29:238-47.
61. Serra C, Bonfill X, Sunyer J et al. Bladder cancer in the textile industry. Scand JWork Environ Health 2000;26:476-81.
62. Castelao JE, Yuan J-M, Skipper PL et al. Gender-and smokingrelated bladder cancer risk. J Natl Cancer Inst 2001;93:538-45.
63. Chiu BC, Lynch CF, Cerhan JR, Cantor KP. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Ann Epidemiol 2001;11:28-37.
64. Vineis P, Marinelli D, Autrup H et al. Current smoking, occupation, n-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 2001;10:1249-52.
65. Pelucchi C, La Vecchia C, Negri E, Dal Maso L, Franceschi S. Smoking and other risk factors for bladder cancer in women. Prev Med 2002;35:114-20.
66. Tripathi A, Folsom AR, Anderson KE. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 2002;95:2316-23.
67. Zeegers MP, Goldbohm RA, van den Brandt PA. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control 2002;13:83-90.
68. Gaertner RR, Trpeski L, Johnson KC. A case-control study of occupational risk factors for bladder cancer in Canada. Cancer Causes Control 2004;15:1007-19.
69. Jee SH, Samet JM, Ohrr H, Kim JH, Kim IS. Smoking and cancer risk in Korean men and women. Cancer Causes Control 2004;15:341-48.
70. Karagas MR, Tosteson TD, Morris JS et al. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 2004;15:465-72.
71. Quirk JT, Li Q, Natarajan N, Mettlin CJ, Cummings KM. Cigarette smoking and the risk of bladder cancer in men and women. Tob Induc Dis 2004;2:1-4.
72. Cao W, Cai L, Rao JY et al. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 2005;104:2400-08.
73. Chen Y-C, Su H-JJ, Guo Y-LL, Houseman EA, Christiani DC. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer. Cancer Causes Control 2005;16:75-81.
74. Bjerregaard BK, Raaschou-Nielsen O, Sørensen M et al. Tobacco smoke and bladder cancer-in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2006;119:2412-16.
75. Cantwell MM, Lacey JV, Schairer C, Schatzkin A, Michaud DS. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer 2006;119:2398-401.
76. Samanic C, Kogevinas M, Dosemeci M et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 2006;15:1348-54.
77. Terry PD, Umbach DM, Taylor JA. APE1 genotype and risk of bladder cancer: evidence for effect modification by smoking. Int J Cancer 2006;118:3170-73.
78. Alberg AJ, Kouzis A, Genkinger JM et al. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol 2007;165:660-66.
79. Jiang X, Yuan J-M, Skipper PL, Tannenbaum SR, Mimi CY. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 2007;67:7540-45.
80. McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007;16:815-19.
81. Demirel F, Cakan M, Yalçinkaya F, Topcuoglu M, Altug U. The association between personal habits and bladder cancer in Turkey. Int Urol Nephrol 2008;40:643-47.
82. Baris D, Karagas MR, Verrill C et al. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 2009;101:1553-61.
83. Cassidy A, Wang W, Wu X, Lin J. Risk of urinary bladder cancer: a case-control analysis of industry and occupation. BMC Can 2009;9:443.
84. Stern MC, Van Den Berg D, Yuan J-M et al. Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Cancer Epidemiol Biomarkers Prev 2009;18:3057-61.
85. Wen H, Ding Q, Fang Z-j, Xia G-w, Fang J. Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai. Int Urol Nephrol 2009;41:855-64.
86. Srivastava P, Gangwar R, Kapoor R, Mittal RD. Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population. Dis Markers 2010;29:37-46.
87. Tao L, Xiang Y-B, Wang R et al. Environmental tobacco smoke in relation to bladder cancer risk-the Shanghai bladder cancer study. Cancer Epidemiol Biomarkers Prev 2010;19:3087-95.
88. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA 2011;306:737.
89. Gangwar R, Mandhani A, Mittal RD. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India. Surgery 2011;149:126-34.
90. MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR. Diabetes and risk of bladder cancer: evidence from a case-control study in New England. Cancer 2011;117:1552-56.
91. Grant EJ, Ozasa K, Preston D et al. Effects of radiation and lifestyle factors on risks of urothelial carcinoma in the life span study of atomic bomb survivors. Radiat Res 2012;178: 86-98.
92. Jiang X, Castelao JE, Yuan JM et al. Cigarette smoking and subtypes of bladder cancer. Int J Cancer 2012;130:896-901.
93. Liu Y, Wang H, Lin T et al. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk. Oncol Rep 2012;28:337-45.
94. Welty CJ, Wright JL, Hotaling JM, Bhatti P, Porter MP, White E. Persistence of urothelial carcinoma of the bladder risk among former smokers: Results from a contemporary, prospective cohort study. Urol Oncol 2014;32:25.
95. Ferreccio C, Yuan Y, Calle J et al. Arsenic, tobacco smoke, and occupation: associations of multiple agents with lung and bladder cancer. Epidemiology 2013;24:898-905.
96. Isa F, Xie L-P, Hu Z et al. Dietary consumption and diet diversity and risk of developing bladder cancer: results from the South and East China case-control study. Cancer Causes Control 2013;24:885-95.
97. Matic M, Pekmezovic T, Djukic T et al. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: A case-control study. Urol Oncol 2013;31:1184-92.
98. Amr S, Dawson R, Saleh Da A et al. Agricultural workers and urinary bladder cancer risk in Egypt. Arch Environ Health 2014;69:3-10.
99. Polesel J, Bosetti C, di Maso M et al. Duration and intensity of tobacco smoking and the risk of papillary and non-papillary transitional cell carcinoma of the bladder. Cancer Causes Control 2014;25:1151-58.
100. Vermeulen S, Hanum N, Grotenhuis A et al. Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer 2015;112:594-600.
101. Baena AV, Allam MF, Del Castillo AS et al. Urinary bladder cancer risk factors in men: a Spanish case-control study. Eur J Cancer Prev 2006;15:498-503.
102. Sadetzki S, Bensal D, Blumstein T, Novikov I, Modan B. Selected risk factors for transitional cell bladder cancer. Med Oncol 2000;17:179-82.
103. Hours M, Dananche B, Fevotte J et al. Bladder cancer and occupational exposures. Scand J Work Environ Health 1994;20:322-30.
104. Jiang X, Castelao JE, Groshen S et al. Alcohol consumption and risk of bladder cancer in Los Angeles County. Int J Cancer 2007;121:839-45.
105. Hartge P, Hoover R, Kantor A. Bladder cancer risk and pipes, cigars, and smokeless tobacco. Cancer 1985;55:901-06.
106. Vineis P, Frea B, Uberti E, Ghisetti V, Terracini B. Bladder cancer and cigarette smoking in males: a case-control study. Tumori 1983;69:17-22.
107. Jensen OM, Wahrendorf J, Blettner M, Knudsen J, Sørensen B. The Copenhagen case-control study of bladder cancer: role of smoking in invasive and non-invasive bladder tumours. J Epidemiol Community Health 1987;41:30-36.
108. Lin J, Spitz MR, Dinney CP, Etzel CJ, Grossman HB, Wu X. Bladder cancer risk as modified by family history and smoking. Cancer 2006;107:705-11.
109. Wang Y-H, Yeh S-D, Wu M-M et al. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer. J Hazard Mater 2013;262:1139-46.
110. McCormack VA, Agudo A, Dahm CC et al. Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2010;127:2402-11.
111. Godschalk RW, Van Schooten F-J, Bartsch H. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. Biochem Mol Biol Int 2003;36:1-11.
112. Poirier MC, Fullerton NF, Smith BA, Beland FA. DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. Carcinogenesis 1995;16:2917-21.
113. Dallinga JW, Pachen D, Wijnhoven S, et al. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. Cancer Epidemiol Biomarkers Prev 1998;7:571-77.
114. Lee PN, Forey BA, Coombs KJ. Systematic review with metaanalysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Can 2012;12:385.
115. Wyss A, Hashibe M, Chuang S-C et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol 2013;178: 679-90.
116. Maasland DH, van den Brandt PA, Kremer B, Goldbohm RAS, Schouten LJ. Alcohol consumption, cigarette smoking and the risk of subtypes of head-neck cancer: results from the Netherlands Cohort Study. BMC Can 2014;14:187.
117. De Vries H, Mudde AN, Dijkstra A, Willemsen MC. Differential beliefs, perceived social influences, and self-efficacy expectations among smokers in various motivational phases. Prev Med 1998;27:681-89.
118. Department of Health and Human Services US. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-attributable Disease. Washington, DC: Centers for Disease Control and Prevention, 2010.
119. Gandini S, Botteri E, Iodice S et al. Tobacco smoking and cancer: A meta-analysis. Int J Cancer 2008;122:155-64.
120. Benowitz NL, Pérez-Stable EJ, Herrera B, Jacob P. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer Inst 2002;94:108-15.
121. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002 CA Cancer 2005;55:74-108.
122. Dreyer L, Winther J, Pukkala E, Andersen A. Tobacco smoking. APMIS 1997;105:9-47.
123. Hedges LV, Vevea JL. Fixed-and random-effects models in meta-analysis. Psychol Methods 1998;3:486.
124. Hartmann A, SchlakeG, ZaakDet al.Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res 2002;62:809-18.
125. Spruck CH, Rideout WM, Olumi AF et al. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res 1993;53:1162-66.
126. García-Closas M, Malats N, Silverman D et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649-59.
127. Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer 2015;15:25-41.